Publications list for Dr Christina Bursill

2013 | 2012 | 2011 | 2010 | 2009

2013

   
  • van der Vorst, E., Vanags, L., Dunn, L., Prosser, H., Rye, K., Bursill, C. (2013), High-density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells. The FASEB Journal. 27(4), 1413-1425. [Abstract]

2012

   
  • Prosser, H., Ng, M., Bursill, C. (2012), The role of cholesterol efflux in mechanisms of endothelial protection by HDL. Current Opinion in Lipidology. 23(3), 182-189. [Abstract]

2011

   
  • Di Bartolo, B., Nicholls, S., Bao, S., Rye, K., Heather, A., Barter, P., Bursill, C. (2011), The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins. Atherosclerosis. 217(2), 395-400. [Abstract]
  • Akram, O., Bursill, C., Desai, R., Heather, A., Kazlauskas, R., Handelsman, D., Lambert, G. (2011), Evaluation of androgenic activity of nutraceutical-derived steroids using mammalian and yeast in vitro androgen bioassays. Analytical Chemistry. 83(6), 2065-2074. [Abstract]
  • Di Bartolo, B., Vanags, L., Tan, J., Bao, S., Rye, K., Barter, P., Bursill, C. (2011), The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit. Lipids in Health and Disease. 10, 224. [Abstract]

2010

   
  • Bursill, C., Castro, M., Beattie, D., Nakhla, S., van der Vorst, E., Heather, A., Barter, P., Rye, K. (2010), High-Density Lipoproteins Suppress Chemokines and Chemokine Receptors In Vitro and In Vivo. Arteriosclerosis, thrombosis, and vascular biology. 30(9), 1773-8. [Abstract]

2009

   
  • Rye, K., Bursill, C., Lambert, G., Tabet, F., Barter, P. (2009), The metabolism and anti-atherogenic properties of HDL. Journal of Lipid Research. 50(Suppl 1), S195-S200. [Abstract]